InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: None

Wednesday, 03/29/2017 6:52:19 PM

Wednesday, March 29, 2017 6:52:19 PM

Post# of 9121
FDA Panel Supports Subcutaneous Rituximab for Blood Cancers Jason M. Broderick @jasoncology Published Online: Wednesday, Mar 29, 2017 - See more at: http://www.onclive.com/web-exclusives/fda-panel-supports-subcutaneous-rituximab-for-blood-cancers#sthash.I4XB72Zb.dpuf

"Subcutaneous rituximab has been available in the European Union under the trade name MabThera since 2014, and is also approved in nearly 50 other countries." - See more at: http://www.onclive.com/web-exclusives/fda-panel-supports-subcutaneous-rituximab-for-blood-cancers#sthash.I4XB72Zb.dpuf

That is new and a recent significant increase in countries launched.

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News